Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

AnJie Law Firm

China

This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
2026 Edition
Trade mark disputes - domestic firms
Other Notable Firms
33 firms ranked
View full list

Tier 1

King & Wood
11 practice areas
View full profile
Wanhuida Intellectual Property
5 practice areas
View full profile

Tier 2

CCPIT Patent and Trademark Law Office
6 practice areas
View full profile
Chang Tsi & Partners
5 practice areas
View full profile
Fangda Partners
17 practice areas
View profile
Han Kun Law Offices
14 practice areas
View full profile
Lifang & Partners
10 practice areas
View full profile
Unitalen Attorneys at Law
9 practice areas
View full profile

Tier 3

China Patent Agent (HK)
6 practice areas
View full profile
Dacheng Law Offices
14 practice areas
View profile
East IP
7 practice areas
View full profile
FenXun Partners
7 practice areas
View profile
GEN Law Firm
11 practice areas
View profile
IntellecPro
4 practice areas
View full profile
JunHe
15 practice areas
View profile
Kangxin Partners
6 practice areas
View full profile
LexField Law Offices
6 practice areas
View profile
Lung Tin IP Attorneys
7 practice areas
View full profile
Lusheng Law Firm
10 practice areas
View full profile
Zhong Lun Law Firm
13 practice areas
View profile

Other Notable Firms

Advance China IP Law Office
7 practice areas
View full profile
AllBright Law Offices
9 practice areas
View profile
An Tian Zhang & Partners
6 practice areas
View profile
AnJie Law Firm
10 practice areas
View profile
DeHeng Law Offices
8 practice areas
View profile
HongFangLaw
8 practice areas
View profile
Jingtian & Gongcheng
9 practice areas
View profile
Lawjay Partners
5 practice areas
View full profile
Liu Shen & Associates
8 practice areas
View full profile
NTD Intellectual Property Attorneys
5 practice areas
View profile
Tahota Law Firm
6 practice areas
View full profile
Tiantai Law Firm
2 practice areas
View profile
Watson & Band
5 practice areas
View profile
Trade mark prosecution - domestic firms
Other Notable Firms
18 firms ranked
View full list

Tier 1

CCPIT Patent and Trademark Law Office
6 practice areas
View full profile
China Patent Agent (HK)
6 practice areas
View full profile
King & Wood
11 practice areas
View full profile
Wanhuida Intellectual Property
5 practice areas
View full profile

Tier 2

Chang Tsi & Partners
5 practice areas
View full profile
East IP
7 practice areas
View full profile
Kangxin Partners
6 practice areas
View full profile
NTD Intellectual Property Attorneys
5 practice areas
View profile
Unitalen Attorneys at Law
9 practice areas
View full profile

Tier 3

IntellecPro
4 practice areas
View full profile
LexField Law Offices
6 practice areas
View profile

Other Notable Firms

AFD China
5 practice areas
View full profile
Advance China IP Law Office
7 practice areas
View full profile
An Tian Zhang & Partners
6 practice areas
View profile
AnJie Law Firm
10 practice areas
View profile
Beijing Sanyou Intellectual Property Agency
4 practice areas
View profile
China PAT Intellectual Property Office
8 practice areas
View full profile
Lung Tin IP Attorneys
7 practice areas
View full profile
2 results2 results
Read the latest news about intellectual property practitioners and firms in Asia-Pacific and Europe
Read the latest IP practitioner hires, departures and other developments in firms operating in the Asia Pacific region
On June 1 2018, the Supreme People’s Court of China (SPC) issued the draft judicial interpretation on patent validity and examination cases for public comments
On June 1 2018, the Supreme People’s Court of China (SPC) issued Provisions on Several Issues in Adjudicating Patent Granting and Affirming Administrative Cases I (the Draft Provisions). The general public can submit its opinions and comments by July 1 2018.
China announced a huge government reshuffle programme. The sweeping government restructuring programme was said to be the largest reform since the end of the Mao Zedong era in the 1970s
Sponsored

Sponsored

MIP Sponsored

  • Sponsored by AnJie Law Firm
    In the US-China Phase One trade deal signed on January 15 2020, notable agreements on patents mostly relate to pharmaceutical sectors – Articles 1.10, 1.11 and 1.12. It is possible that these articles may also have implications for other sectors, which remains to be seen in the subsequent implementation. In addition, the provisions on judicial enforcement and procedures should benefit all patent owners. More technical issues such as indirect infringement or changes to the judicial review of invalidation decisions are not addressed. This update provides a brief overview of these key changes.
  • Sponsored by AnJie Law Firm
    On January 15 2020, US President Donald Trump and Chinese vice-premier He Liu signed a trade agreement which President Trump has described as "the biggest deal anybody has ever seen." The deal promises to be the first phase of a larger new trade agreement between the US and China, announcing a significant de-escalation in the trade war between the two giants that has dragged along for more than one year. Of particular interest to those in the pharmaceutical industry will be Sections C and D of the first chapter of the trade agreement, which outline China's commitments to improve protection and enforcement of pharmaceutical-related patent rights, and in particular to creating an effective mechanism for early resolution of patent disputes between generic drug companies and pharmaceutical innovators, or a Chinese drug patent linkage system, as many may like to put it.
  • Sponsored by AnJie Law Firm
    Back at the end of April, the Committee of the Science and Technology Innovation Board at the Shanghai Stock Exchange announced that the meeting for reviewing the initial public offering (IPO) application of MEMSensing, a Chinese MEMS microphone sensor supplier, was cancelled due to an "emergence of significant matters." The "significant matters" they were referring to were 16 patent disputes brought by Goertek seeking both permanent injunctions and damages totalling over RMB 100 million ($14.5 million). Goertek and MEMSensing are competitors producing MEMS microphones, a key component in the smart speakers of Google, Amazon, Apple, Alibaba, and Xiaomi.